Continuous belly pressure monitoring during pulsed field ablation for atrial fibrillation/flutter

Comparative Study of Intra-abdominal Pressure Using Accuryn Monitoring System During Pulsed Field Ablation (PFA) for Treatment of Atrial Fibrillation and/or Atrial Flutter Under Sedation.

Not applicable Interventional Wake Forest University Health Sciences · NCT06876896

This will test whether using an Accuryn Foley catheter to continuously measure intra-abdominal pressure during pulsed field ablation can reveal pressure changes related to different types of anesthesia in adults treated for atrial fibrillation or atrial flutter.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment50 (estimated)
Ages18 Years and up
SexAll
SponsorWake Forest University Health Sciences Academic / other
Locations1 site (Winston-Salem, North Carolina)
Trial IDNCT06876896 on ClinicalTrials.gov

What this trial studies

This single-center interventional study uses the Accuryn Foley catheter to record continuous intra-abdominal pressure (IAP) and urine output during pulsed field ablation (PFA) procedures in adults with atrial fibrillation or atrial flutter. Participants will undergo standard-of-care PFA while investigators collect real-time IAP data and compare pressure patterns between different anesthetic approaches. The protocol excludes patients with recent intra-abdominal surgery, contraindications to bladder catheterization, pregnancy, and those with COPD on home oxygen. Investigators aim to correlate IAP changes with procedure-related risks such as aspiration or respiratory compromise and to determine whether anesthesia choice influences those responses.

Who should consider this trial

Good fit: Ideal candidates are adults having clinically indicated pulsed field ablation for atrial fibrillation or atrial flutter who can safely receive a Foley catheter and have no recent intra-abdominal surgery or other contraindications to bladder catheterization.

Not a fit: Patients who are pregnant, unable to have bladder catheterization, have recent intra-abdominal surgery, frequent urinary infections or require home oxygen for COPD are unlikely to benefit or be eligible for this protocol.

Why it matters

Potential benefit: If successful, continuous IAP monitoring could help clinicians detect dangerous pressure rises during PFA and prompt interventions that reduce aspiration risk and unplanned admissions.

How similar studies have performed: Foley-based continuous IAP monitoring is FDA-cleared and used in surgical and critical care settings, but its specific use during PFA for atrial arrhythmias is a novel application with limited prior data.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients receiving pulse field ablation procedures for standard of care treatment of atrial fibrillation and/or atrial flutter.
* Eligible for Foley catheter placement with no contraindications to Intra-abdominal pressure (IAP) monitoring.

Exclusion Criteria:

* Patients under the age of 18 will be excluded.
* History of intra-abdominal surgery within the past 6 months.
* Known contraindications to bladder catheterization or catheter ablation; history of prostate issues / Benign prostatic hyperplasia (BPH) or frequent urinary tract infections
* Pregnant or breastfeeding individuals
* History of chronic obstructive pulmonary disease (COPD) with home oxygen use

Where this trial is running

Winston-Salem, North Carolina

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Intra-Abdominal HypertensionAtrial FibrillationAtrial FlutterPulsed Field Ablation
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.